Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-... von Gentile, I, Viceconte, G, Cuccurullo, F, Pietroluongo, D, D'Agostino, A, Silvitelli, M, Mercinelli, S, Scotto, R, Grimaldi, F, Palmieri, S, Gravetti, A, Trastulli, F, Moccia, M, Buonomo, A R

Volltext